Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flaxseed mucilage is a viscous, gel-like substance extracted from flaxseeds (also known as linseeds) when they are exposed to aqueous fluids. It consists primarily of polysaccharides including arabinoxylan and rhamnogalacturonans[3]. This natural substance has multiple therapeutic applications due to its ability to form a slippery gel that can act as a bulking laxative, stool softener, and drug carrier[4][1]. The mucilage has several beneficial properties: - **Laxative Effect**: When consumed, flaxseed mucilage absorbs water in the digestive tract, increasing stool volume and triggering intestinal movement while also moistening the stool to ease passage[4][1]. - **Anti-inflammatory Properties**: It demonstrates anti-inflammatory effects, potentially by decreasing circulating levels of C-reactive protein (CRP), a marker of inflammation[3]. - **Antimicrobial Activity**: Research indicates effectiveness against several bacterial strains including Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus[3]. - **Drug Delivery Capabilities**: The mucilage can be formulated into films for controlled drug release, as demonstrated in periodontal treatment applications[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Flaxseed mucilage.